Q - By Satish Gupta of ht(tp:/)/ww(w)astrostocktips.)in Today’s planetary position - Moon will be transiting in Capricorn, Debilitated Mars in Cancer. Ketu in Gemini, Retrograde Saturn in Virgo, Rahu & Pluto in Sagittarius, Sun, Jupiter, Mercury & Neptune in Aquarius, Venus & Uranus in Pisces. UQ - One shall remember Sun in Min rashi which denotes Steel sector will dow within next 3-4 days.. Stcks starting with "T " AND " "S" shall be watched on Weekly Resistance levels to Short...... AStro is not a cup of tea is every one. however, this is what I know something...I can post Shorting levels of Tata Steel, JSW Steel AND Sesa Goa.. However, every one can get Res levels of 5DMA very easily.. If you want that level, read my article... for all three stocks... --SK--...

Technicall Nifty may taste 5111 today......

NSE Symbol MICROTECH Result Period 01-OCT-2009 to 31-DEC-2009 (Third Quarter) Result Type Unaudited, Non-Cumulative, Consolidated Non Banking Description Amount(Rs. in lakhs) Net Sales/Income from Operations 11822.13 Other Operating Income - Increase/Decrease in Stock in trade and work in progress - Consumption of Raw Materials - Purchase of traded goods - Employees Cost 273.90 Depreciation 1031.50 Other Expenditure 7587.38 Total Expenditure 8892.78 Profit from Operations before Other Income, Interest & Exceptional Items 2929.35 Other Income 79.87 Profit before Interest & Exceptional Items 3009.22 Interest 253.31 Profit after Interest but before Exceptional Items 2755.91 Exceptional items - Profit(+)/Loss(-) from Ordinary Activities before tax 2755.91 Tax Expense 468.10 Net Profit(+)/Loss(-) from Ordinary Activities after tax 2287.81 Extraordinary Items - Net Profit (+) / Loss (-) for the period 2287.81 Minority Interest 18.16 Shares of Associates - Other Related Items - Consolidated Net Profit (+) / Loss (-) for the period 2269.65 Dividend (%) - Face Value (in Rs.) 10.00 Paid-up Equity Share Capital 1097.65 Reserves excluding Revaluation Reserves - Basic EPS before Extraordinary items (in Rs.) 20.68 Diluted EPS before Extraordinary items (in Rs.) 16.36 Basic EPS after Extraordinary items (in Rs.) 20.68 Diluted EPS after Extraordinary items (in Rs.) 16.36 Public Shareholding (Number of Shares) - Public Shareholding (%) - Promoter & Promoter group Number of Shares Pledged / Encumbered 1205000.00 Promoter & Promoter group Shares Pledged / Encumbered (as a % of total shareholding of Promoter and Promoter Group) 33.79 Promoter & Promoter group Shares Pledged / Encumbered (as a % total share capital of the company) 10.98 Promoter & Promoter group Number of Shares Non-encumbered 2361182.00 Promoter & Promoter group Shares Non-encumbered (as a % of total shareholding of Promoter and Promoter Group) 66.21 Promoter & Promoter group Shares Non-encumbered (as a % total share capital of the company) 21.51 Notes To Accounts ...

For all the beautiful Women ‘and’ for the kind-hearted Men, who are wishing us Happy Women’s day!!! SHE HUGGED YOU WARMLY WHEN YOU CAME FROM SCHOOL.... SHE LEFT HER HOME TO STAND SHOULDER To SHOULDER WITH YOU... SHE IS THE PIG-TAILED LITTLE LITTLE DEVIL WHO SHARED YOUR CHILDHOOD SECRETS.. SHE IS YOUR LITTLE BUNDLE,WHO BRINGS OUT A TENDER SIDE IN YOU... SHE IS YOUR MOTHER,WIFE,SISTER, DAUGHTER She Guides you well and Pats Your Back.. She Shares Your Goals and Supports you through Tasks.. She is an Eager Learner, a Smart Worker,a Fun Team-Mate... She Shares your day`s highs and lows.. She is your Strength.... SHE IS YOUR BOSS, COLLEAGUE,TEAM-MATE,FRIEND..... She strives to ensure your world is alive with freedom......... She inspires you to be you.... SHE IS AND HENCE YOU ARE..... She is a Teacher,an Archiever,a Life coach and a inspiration......... Cheers to The WOMEN in your LIFE...... Celebrate the women in your life , today!!!!!! ...

Daily News Letter is Posted on Web site KI-TRADE. It is not possible to re post here. Dispaly is delayed beyong tolerence. --SK--...

Guest, If you refer me, I am happy to say that- IFCI Rocked .. 48 to 59 20 % up.. Axis Bank Corp bank were day trading calls and gave good profits..!!!!!!!! --SK-- Now Renuka : CA_ 190 CMP 2.55 Close.. Target 12-15 lot size 2500.. Profits : You can count.. stop Loss Rs. 2/- Max loss = ( 2.55 - 0.55 = 0.55 x 2500 ) Hardly 2000 with Brokerage.. --SK- Watch SBI on Monday . our BTST CALL.....

Thursday FII ACTIVITIES : FIIs bought stocks worth Rs 634 crore whereas DIIs sold stocks worth Rs 636 crore. FIIs booked profit in index futures to the tune of Rs 728 crore and created shorts in stock futures to the tune of Rs 196 crore ...

Short term target Rs 600. Safe pick at current levels. Buy in bulk. This is purely my thinking and suggest take your own decision....

moneyman1973, If someone is interested, let them buy Beckons. Why to discourage them? From Rs. 9.20 onwards I am watching this stock and a clean 45% profit from that level when the stock hit todays high. Let us not spoil others opportunities. Try to promote the stocks which are of interest to you and suggest dont waste your time in Beckons board....

Just wait for six months. It should gain momentum. Nothing much to loose from this level. I would like to see it cross Rs. 12. Seems that it is now in 10% circuit....

Suggest add 500 more and hold for long term with a target of Rs. 100, expected to achieve in one year. Keep stop loss at Rs. 27. Fast growing Comapny with good client base....

Punj Llyod trading at Rs. 205. Still looks good....

Voltas trading at Rs. 173....

Hanung Toys now trading at Rs. 113. Congrats....

Hanung Toys now trading at Rs. 113. Congrats....

Following information taken from a pre IPO analysis in May 2008.
Quote:-
Anu’s Laboratories, Started in Hyderabad in 1996 by K. Hari Babu, Anu’s Laboratories e manufactures basic and advanced intermediates and fine chemicals. Some of the key intermediates produced are 2,4-dichloro-5-fluoro acetophenone (DCFA) (an intermediate for synthesising quinolone antibiotics like ciprofloxacin), chlorohexanone (key intermediate in the manufacture of cardio vascular medicine), methyl-4 (4-chloro, 1 oxo butyl),and di-methyl acetate (an intermediate used to manufacture Fexofenadine, an anti allergic drug). These three intermediates accounted for around 29%, 24% and 9% of the company’s sales in the nine months ended December 2007. Exports to Israel, Italy, Japan, France, USA and Singapore accounted for around 20% of the sales in this period.

As a forward-integration measure, Anu’s Laboratories has proposed setting up a plant for manufacturing drug intermediates including active pharma ingredients (APIs) at Jawaharlal Nehru Pharma City, Vishakhapatnam, Andhra Pradesh, for Rs 55.09 crore. Land measuring 9.54 acres has been purchased by paying an initial sum of Rs 0.91 crore. A separate development-cum-service agreement for development of this land has been entered with Andhra Pradesh Industrial Infrastructure Corporation (APIIC) and Ramky Pharma City (Ramky). Commercial operations are expected by April 2009.

To bolster its contract research and manufacturing (CRAMS) & R&D operations, Anu’s Laboratories is to set up a pilot plant at Jawaharlal Nehru Pharma City for Rs 8.34 crore. From the IPO proceeds, Rs 16.67 crore is to be earmarked for meeting long-term working capital requirement.

From internal accruals, Rs 12 crore will be deployed for the expansion programme and meeting issue expenses. By 7 April 2008, Rs 1.29 crore had been utilised.

Weaknesses

Around 53% of the revenue was from the sale of two products: DCFA and CIS Lactum in the nine months ended December 2007. Any decline in the sales of these products or potential substitute or volatility in the prices of these products may adversely affect the financial performance.

Dr. Reddy’s Laboratories accounted for around 47% of the revenue.

About 34% of the sales were from products manufacturing, outsourced to a promoter group company, Nitya Laboratories. This can lead to conflict of interest. Moreover, Nitya Lab has been incurring losses, has overdues to banks and is involved in various legal proceedings.

Valuation

Anu’s Laboratories has set a price band of Rs 200 to Rs 210 per equity share of Rs 10 face value. At the lower band of Rs 200 per share, the P/E would be 13.8x times annualised EPS of Rs 14.5 for the nine months ended December 2007 and 17.8x times the EPS of Rs 11.3 for the year ending March 2007 (FY 2007) on post-issue equity of Rs 12.08 crore. At the upper band of Rs 210 per share, the P/E would be 14.5x times and 18.7x times, respectively. In the pharmaceutical industry (bulk drug and intermediates), comparable companies such as Neuland Labs, Aarti Drugs and SMS Pharma have TTM P/E of around 9.5, 4.8 and 10.4, respectively.

Unquote:-
Hope above information will be of help to those who want to know more about the Company, before investing.
...

The way market gone up today, many people may think thate volumes and turnover was huge , but on the contarary it was too less and no trading happened in many counters. Just see a few from the sensex pack.
ACC - 2346
AIRTEL - 9219
BHEL- 8419
DLF - 59378
GRASIM - 1327
HDFC - 3232
HDFC BANK - 1687
INFOSYS - 5215
ITC - 5029

As per my thought, those who bought today have invited some risk and those were holding since the past few days are now in an advantageous and these people will try to book profit tomorrow. Hence most probabaly we may see some selling pressure during tomorrow one hour session. However we are witnessing a new scenario at the moment and feel that tomorrow investors will make a cautious approach, because majority investors will be watching the discussions on this topic today and seeking openions from others as to what should be tomorrows strategy. Now the words of caution might have already spread in the market and ofcourse nothing to panic, since everyone is with a positive frame of mind after the results.



...

Why Tanla when we have better options. These targets were given all most one year back and it never achieved those targets even when the markets were bullish. See the fate if this stock, its on pathetic level of Rs. 50....

It may look very interesting for you to see other loosing money. Everybody knows that people stuck in this stock at the moment are genuine investors and they have nothing to do with any manipulations. If SEBI is so concerned, they should investigae and find out the culprits and punish them. Now with this action whose interest is safeguarded ? Such actions are intended for genuine investors not to loose money, but this action did exactly the opposite. All those traders got advance notice to move out of the stock and no one is there with Akruti at this moment. ...